Drugs Made In America Acquisition (DMAA) Technical Analysis

As of 2026-07-22, DMAA last traded at 10.7 USD (0.00% on the day) and is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Nearest levels: 10.607 USD support below, no clear near resistance above. 14-day RSI is 71.4 (overbought).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is DMAA in an uptrend or downtrend?

Drugs Made In America Acquisition is in a uptrend — price above rising 50-DMA, 50-DMA above 200-DMA.

Last close10.7 USD (0.00%)
20-day average10.662 USD
50-day average10.629 USD
200-day average10.468 USD

Key support and resistance levels for DMAA

Derived from swing pivots over the last 200 sessions:

No clearly-defined swing levels in the current range.

LevelTypeStrengthTouches
10.607 USDSupportStrong9
10.491 USDSupportStrong9
10.357 USDSupportStrong22

DMAA 52-week range, momentum and volatility

52-week high10.7 USD (0% below)
52-week low10.22 USD (4.7% above)
14-day RSI71.4 (Overbought)
14-day ATR0.02 USD (0.19% of price, Low volatility)

Related research pages

Frequently asked questions

Is Drugs Made In America Acquisition (DMAA) in an uptrend or downtrend?

As of 2026-07-22, DMAA is in a uptrend on the daily timeframe — price above rising 50-DMA, 50-DMA above 200-DMA. Last close 10.7 USD vs 50-day average 10.629 USD and 200-day average 10.468 USD.

What are the key support and resistance levels for DMAA?

Nearest support is around 10.607 USD (strong, 9 touches). No clear resistance above price in range. Levels are derived from swing pivots over the last ~200 sessions.

What is DMAA's 52-week high and low?

Over the last 52 weeks, DMAA traded between 10.22 USD and 10.7 USD. It is currently 0.0% below its 52-week high.

Is DMAA overbought or oversold?

The 14-day RSI is 71.4 — in overbought territory (>70). Momentum reads as overbought.

How volatile is DMAA?

Its 14-day Average True Range is 0.02 (0.19% of price) — low volatility relative to price.